13F Holdings
中文EN

CFOO China Foods Holdings Ltd.

Medicinal Chemicals & Botanical Products · OTC · SEC CIK 1310630 · Fiscal year ends 12/31

Financial factors as of 2026-06-30 (2026Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY-46.6%
TTM net income YoY33.6%
TTM EPS YoY0.0%
Revenue 3-yr CAGR-3.9%
Net income 3-yr CAGR—

Margins

Gross margin7.9%
Operating margin-173.9%
Net margin-173.8%
FCF margin—
EBITDA margin-170.1%

Returns

ROE—
ROA-114.1%
ROIC (approx.)—
Asset turnover0.66x

Leverage & solvency

Liabilities / assets756.1%
Debt / equity—
Current ratio0.11x
Interest coverage—

Cash quality & payout

Operating cash flow / net income1.09x
Accruals ratio10.3%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$327,871$233,339$158,475$354,096$361,116
Cost of revenue$297,909$179,466$94,331$243,034$121,690
Gross profit$29,962$53,873$64,144$111,062$239,426
SG&A expense$423,644$502,654$465,234$500,807$690,780
Operating income-$398,923-$455,637-$404,637-$392,733-$456,430
Pretax income-$398,672-$454,735-$403,700-$353,250-$448,738
Income tax—$836—$828$6,671
Net income-$398,672-$455,571-$403,700-$354,078-$455,409
EBITDA-$391,934-$453,869-$362,247-$327,568-$365,469
EPS (basic)-0.02-0.02-0.02-0.02-0.02
EPS (diluted)-0.02-0.02-0.02-0.02-0.02
Weighted avg. shares (diluted)20.25M20.25M20.25M20.25M20.25M
Banking
Net interest income$45$329$594$190$1,277
Balance sheet
Cash & equivalents$9,893$39,192$174,877$381,709$609,434
Receivables——$38,831$5,120—
Inventory$39,255$54,943$48,282$138,582$327,551
Current assets$162,943$398,686$349,603$600,224$1.09M
PP&E, net$27,860$34,264$12,981$55,495$132,604
Intangibles$1,662$2,055$2,597$3,148$3,947
Total assets$212,890$435,005$365,181$679,208$1.57M
Current liabilities$1.48M$1.29M$755,996$661,779$925,540
Total liabilities$1.49M$1.29M$755,996$661,779$1.17M
Shareholders' equity-$1.28M-$850,807-$390,815$17,429$400,701
Shares outstanding20.25M20.25M20.25M20.25M20.25M
Cash flow statement
Operating cash flow-$389,251-$353,812-$316,916-$171,598-$438,620
Capital expenditure—$23,454$746—$27,358
Free cash flow—-$377,266-$317,662—-$465,978
Investing cash flow—-$23,454-$746$22,930-$27,358
Financing cash flow$388,605$245,524$114,270-$52,688$50,319
Depreciation & amortization$6,989$1,768$42,390$65,165$90,961

Free plan shows the latest 5 periods; Pro shows all 23 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.